A multicenter, randomized controlled, non-inferiority trial, comparing nasal continuous positive airway pressure with nasal intermittent positive pressure ventilation as primary support before minimally invasive surfactant administration for preterm infants with respiratory distress syndrome (the NIV-MISA-RDS trial): Study protocol

BACKGROUND: Non-invasive ventilation (NIV) treatment has been developed to minimize lung damage and to avoid invasive mechanical ventilation (IMV) in preterm infants, especially in those with a gestational age of <30 weeks. Our hypothesis is that for preterm infants <30 weeks with potential to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hui, Li, Jun, Zeng, Lin, Gao, Yajuan, Zhao, Wanjun, Han, Tongyan, Tong, Xiaomei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372355/
https://www.ncbi.nlm.nih.gov/pubmed/35967549
http://dx.doi.org/10.3389/fped.2022.968462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372355/
https://www.ncbi.nlm.nih.gov/pubmed/35967549
http://dx.doi.org/10.3389/fped.2022.968462

Ejemplares similares